The patients died of a deadly brain infection known as PML, and 24 cases of the disease have been diagnosed since Tysabri was reintroduced to the market in 2006, the European Medicines Agency told...

The Alabama Supreme Court has thrown out jury decisions awarding the state more than $274 million from three pharmaceutical companies - AstraZeneca, Novartis and GlaxoSmithKline - that had been...

Questions over undisclosed study results, as it turns out, aren’t confined to companies that make medicines. An interesting piece in The Wall Street Journal reports that researchers from the U.S. Army and Thailand didn’t publicly disclose...

Could this be considered an unapproved use? A 60-year-old Afghan tribal chief with four younger wives was given a few of the Pfizer impotence pills by a CIA officer, who returned a few days later...

We apologize for the belated greetings - we know Hanukah began a few nights ago and that Christmas Eve is well under way. But we have had a scattered day and were actually to begin our own...

Yet another drugmaker is uttering the ‘T’ word - transparency. This time around, GlaxoSmithKline has published a list of fees paid between April 1 and June 30 to US healthcare professionals for speaking and consulting services. The drugmaker plans to...

This is the sort of condition that doesn’t come up at dinner parties, or too many other places, we imagine. Yet the recent push to develop a med to treat the problem is getting more press, not surprisingly. The New York Times, for instance, ran a...

Jean-Marc Huet, who joined the drugmaker in mid-2008 as senior vice president and chief financial officer, as it tried to dig its way out of several holes, is leaving this month to return to Europe, according to a statement (that’s Huet in the...

The big drugmaker has paid almost $1 billion to resolve lawsuits since launching its antidepressant in 1993, including about $390 million for suicides or attempted suicides said to be linked to the pill, Bloomberg News reports. The total including...

Kids covered by Medicaid are given antipsychotics four times as often as children whose parents have private insurance, and Medicaid children are more likely to receive the drugs for less severe conditions than their middle-class counterparts, The New...